Factory wholesale price hot selling high purity peptide Tirzepatide for weight loss and anti-aging Cas 2023788-19-2

  Product Detail  

• 

• What is Retatrutide?

  Retatrutide (LY3437943) acetate is a triple agonist peptide for the glucagon receptor (GCGR), glucose-dependent otropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R).

  Retatrutide acetate inhibits human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643, and 0.775 nM, respectively. It exhibits activity on mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191, and 0.794 nM, respectively.

  In vivo, Retatrutide (LY3437943) acetate engages with GCGR and enhances glucose tolerance in an ipGTT by acting through GIP or GLP-1 receptors. Activation via the glucagon receptor by Retatrutide acetate leads to significant weight reduction and increased energy expenditure. Retatrutide acetate can be utilized in research related to obesity.

• 

• Appearance: Powder

  Purity: >98% (or refer to the Certificate of Analysis)

  Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

  Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

  Solubility: To be determined

  Shelf Life: >2 years if stored properly

  Drug Formulation: To be determined

  Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

  HS Tariff Code: 2934.99.9001

• 
  
• Product Specification:                                                   
• 
  

• Items	Specifications
  Product Name	Tirzepatide
  CAS No.	2023788-19-2
  Purity	>99.0%
  Solubility	Dissolved in dimethyl sulfoxide
  Storage condition	-20°C
  Application	Weight loss
  EINECS	200-001-8

• 
  

  Company Profile                                                            

    Changsha Duole Technology Co., Ltd was established in 2020 with strong research and development capabilities and superb synthesis technology, as well as advanced quality control measures.

    With synthetic biology platform technology as the core, it conducts innovative research and development, mainly engaged in the research and development of recombinantly expressed pharmaceutical peptides and proteins. Its products include innovative drugs, APIs, pharmaceutical and green synthetic industrial enzymes, functional peptides and protein products, etc.

    Its core team is composed of technical experts in the fields of pharmaceutical engineering, fermentation engineering and protein engineering. The company has built a 3,300-square-meter recombinant drug research and development center in Shibei, Yuelu District, Changsha City. It has a complete pharmaceutical engineering, preparation and quality research system and talent team, and has built a GMP workshop to meet the international market API supply and CDMO services.

    At present, our company has realized the industrialization of a variety of biosynthetic peptide products and has obtained cooperation orders from many well-known domestic and foreign pharmaceutical companies.